Published in Bioterrorism Week, June 19th, 2006
According to a report from England, "There is a requirement for vaccines to protect against pathogens that may be misused for bioterrorism or biowarfare purposes. In particular, biodefense vaccines are required that may be used for safe and easy immunization of populations and that can rapidly induce mucosal immunity to provide protection at the lung surface against a range of airborne agents."
"To address this need, recombinant Salmonella vaccines are being developed," said Helen S. Atkins and colleagues at the Defense Science and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.